FDA approval of Wegovy expands coverage access for Medicare beneficiaries
- Following new FDA approvals for Wegovy, one in four Medicare beneficiaries with obesity may gain coverage access to the drug to reduce the risk of heart attacks and stroke, according to KFF data. The FDA’s approval of using Wegovy to combat the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese...
